The expiration of the Humira® (adalimumab) patent has been long and enthusiastically anticipated and is finally upon us in 2023. And, as we all have
2022 is coming to an end, leaving many eager to see what the new year has in store. What can we expect in the pharmacy
At National CooperativeRx, we conduct an annual member and partner satisfaction survey to assess our performance, the importance of specific National CooperativeRx aspects, and the
We are pleased to announce the addition of Ricky Neault to our Cooperative team! As a sales and account associate, Ricky will collaborate with our
National CooperativeRx continually monitors the pharmaceutical pipeline. The pharmacy market is dynamic and complex, and it’s important to understand how changes may impact your plan
We are pleased to introduce Annika VanRossum to the National CooperativeRx team! Annika is joining the team as our administrative assistant and will provide administrative
